AbbVie Inc (ABBV)
203.55
-0.32
(-0.16%)
USD |
NYSE |
Nov 01, 16:00
203.53
-0.02
(-0.01%)
After-Hours: 20:00
AbbVie Market Cap: 359.54B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 359.54B |
| October 31, 2024 | 360.10B |
| October 30, 2024 | 355.92B |
| October 29, 2024 | 334.63B |
| October 28, 2024 | 335.04B |
| October 25, 2024 | 331.81B |
| October 24, 2024 | 334.99B |
| October 23, 2024 | 331.86B |
| October 22, 2024 | 333.42B |
| October 21, 2024 | 329.49B |
| October 18, 2024 | 333.59B |
| October 17, 2024 | 333.08B |
| October 16, 2024 | 336.42B |
| October 15, 2024 | 338.89B |
| October 14, 2024 | 345.59B |
| October 11, 2024 | 343.01B |
| October 10, 2024 | 343.29B |
| October 09, 2024 | 344.00B |
| October 08, 2024 | 340.92B |
| October 07, 2024 | 341.98B |
| October 04, 2024 | 343.18B |
| October 03, 2024 | 345.23B |
| October 02, 2024 | 347.65B |
| October 01, 2024 | 347.90B |
| September 30, 2024 | 348.82B |
| Date | Value |
|---|---|
| September 27, 2024 | 344.07B |
| September 26, 2024 | 338.96B |
| September 25, 2024 | 337.83B |
| September 24, 2024 | 341.81B |
| September 23, 2024 | 342.37B |
| September 20, 2024 | 341.73B |
| September 19, 2024 | 342.00B |
| September 18, 2024 | 340.80B |
| September 17, 2024 | 341.70B |
| September 16, 2024 | 345.73B |
| September 13, 2024 | 343.04B |
| September 12, 2024 | 342.71B |
| September 11, 2024 | 343.71B |
| September 10, 2024 | 352.12B |
| September 09, 2024 | 346.95B |
| September 06, 2024 | 341.61B |
| September 05, 2024 | 340.66B |
| September 04, 2024 | 347.99B |
| September 03, 2024 | 349.19B |
| August 30, 2024 | 346.75B |
| August 29, 2024 | 344.75B |
| August 28, 2024 | 345.14B |
| August 27, 2024 | 346.06B |
| August 26, 2024 | 348.75B |
| August 23, 2024 | 348.94B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
95.25B
Minimum
Mar 23 2020
360.10B
Maximum
Oct 31 2024
231.79B
Average
244.81B
Median
Market Cap Benchmarks
| Amgen Inc | 171.59B |
| Johnson & Johnson | 385.53B |
| Eli Lilly and Co | 777.42B |
| Merck & Co Inc | 258.25B |
| Pfizer Inc | 159.18B |
Market Cap Related Metrics
| PE Ratio | 70.68 |
| PS Ratio | 6.499 |
| Price to Book Value | 53.04 |
| Price | 203.55 |
| Earnings Yield | 1.41% |
| Operating PE Ratio | 24.05 |
| Normalized PE Ratio | 60.85 |